Erectile dysfunctions are not uncommon, especially in patients suffering from metabolic syndrome and from a number of circulatory and psychiatric problems. cGMP diesterase inhibitors, such as sildenafil, have proven to be beneficial in the treatment of many such conditions. Our patients, all of them complaining of erectile dysfunction, were treated with sildenafil (50 mg, thrice a week for 6 weeks). All patients reported beneficial effects and were not clinically distinguishable (interview and Doppler scores). We sampled blood for systemic circulation (cubital vein) and from penis (corpora cavernosa) before and after prolonged sildenafil treatment, and measured nitrate ( þ nitrite) levels in plasma and in red blood cells (RBCs). Hemoglobin is a powerful catalyst of NO oxidation to nitrate, and we thought that nitrate in RBC might be a more sensitive parameter than plasma nitrate. We found that the ratio of penile vs systemic blood plasma nitrate was similar in all patients before or after sildenafil treatment. On the other hand, the same parameter measured in RBC showed that, at the beginning of treatment, patients could be divided into two groups: one with a high ratio and the other with a low ratio. Therefore, clinically similar patients could be biochemically divided into two populations. The difference disappeared after treatment, thus hinting at a curative effect of the drug. The mechanisms underlying this behavior are still unknown and the clinical implication of two populations that can be distinguished by RBC nitrate is yet to be evaluated.
Introduction
Erection requires the intervention of neurological, vascular, hormonal and psychological factors. Erectile dysfunction is usually associated with a number of conditions: hypertension, hyperlipidemia, diabetes, stress and cigarette smoke, all of which imply an increased risk of cardiovascular disease. 1 Endothelial-derived factors mediate the vasodilatation necessary for erection to occur; among these, NO is of chief importance. 2 It acts through the stimulation of cyclic GMP (cGMP) production. The endothelium of lacunar spaces and the intima of penile arteries contribute to the local release of NO, 3 which diffuses into trabecular smooth muscle cells and stimulates the synthesis of cGMP by guanylate cyclase, thus determining the relaxation of cavernous and vascular smooth muscle and inducing erection. The mechanism of endothelial dysfunction is multifactorial and the results so far published in literature indicate that altered levels of NO may be important causal factors for this condition. 4 Oxidative stress has been considered to be a possible cause for erectile dysfunction. 4, 5 It implies an increase in the concentration of superoxide, which rapidly reacts with NO forming peroxynitrites, thus reducing NO availability. Peroxynitrites show an elevated cytotoxicity 6 because they can peroxidate membrane lipids, thereby inhibiting a number of regulatory enzymes.
Peroxynitrites, similar to NO, relax vasal muscular cells, although they are less powerful than NO to this effect. The kinetics of relaxation are much different, as the action of peroxynitrites is slower than that of NO. Moreover, superoxide has a direct vasoconstrictor effect 7 and opposes the physiological erection mechanism. Endothelial cell apoptosis, caused by both peroxynitrites and superoxide, further removes NO. [8] [9] [10] The therapy of erectile dysfunction includes phosphodiesterase inhibitors (PDE-5), such as sildenafil and other compounds. 11 Recent evidence [12] [13] [14] [15] suggests that a long-term treatment with these drugs may improve erectile function by influencing penile and systemic vascular parameters (endothelial rehabilitation), although no molecular mechanisms have been proposed for this action.
In this study, we evaluate NO metabolites (nitrates and nitrites) in cavernous and in peripheral red blood cells and plasma before and after a prolonged treatment with sildenafil, in patients affected by erectile dysfunction associated with hypertension and, in some instances, also with diabetes. We propose that a prolonged treatment with cGMP phosphodiesterase inhibitors may help normalize NO metabolism.
Materials and methods

Patients
In this paper, we evaluate 20 patients, all of them being affected by erectile dysfunction and hypertension and seven being diabetic for 2 years. Erection was obtained by injecting 10 mg of prostaglandin E 1 (Caverjet, Pfizer, New York, USA) into the cavernous bodies. Blood was then drawn in EDTA (5 ml from the penis and 5 ml from the peripheral blood) to assess plasma and erythrocyte nitrate. Patients were successively treated for 6 weeks with sildenafil (50 mg Â 3 times a week). The drug was taken in the evening, before bedtime. After treatment, blood was again sampled from all patients to determine nitrate, as reported below.
Patients were evaluated before and after sildenafil treatment using the international index of erectile function questionnaire 16 (questions 1-5 and 15), and the circulatory status in the penis was evaluated by eco-Doppler assessment.
Preparation of plasma and red blood cells
Plasma and erythrocytes were separated by centrifugation of 5 ml of blood for 10 min at 1 500 g.
The concentration of hemoglobin (Hb) in intact red blood cell (RBC) was expressed as the concentration of oxyHb released after lysis, achieved by pelleting the cells and suspending them in the same volume of distilled water. OxyHb was determined by measuring light absorbance at 415 nm. Lysed RBCs were freed of Hb (which would have interfered with nitrate determination) by boiling at 100 1C for 2 min. Samples were then centrifuged at 5 000 g for 10 min. The clear supernatant was collected and used for nitrite/nitrate determination.
Nitrite/nitrate determination Plasma (50 ml) or the Hb-free samples prepared as described above (50 ml) were mixed with 200 ml of 0.1 M CuSO 4 and 50 mg of Cd to transform nitrate into nitrite. After centrifugation at 5 000 g for 2 min, the supernatant was injected into the reaction chamber of the system in which nitrite was converted into NO after a reaction with cysteine and CuCl 2 . Gaseous NO was then measured using electrochemical assay. All these procedures are described in detail by Palmerini et al.
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Results
The characteristics of the patients who participated in this study are presented in Table 1 , which also reports nitrate ( þ nitrite) concentration in penile and systemic RBCs and plasma before and after treatment with sildenafil.
All the patients (46-75-year-old) coming to our department had erectile problems. All of them were affected by hypertension and seven were diabetic as well. All patients reported advantages from sildenafil treatment as shown by the international index of erectile function questionnaire. The beneficial effects were more evident as treatment time increased. Eco-Doppler assessment gave normal results either before or after treatment.
To avoid variations due to basic nitrate or nitrite concentrations in the blood, we compared peripheral blood with cavernous blood samples during erection and expressed the results as the ratio between RBC or plasma nitrate in penile vs systemic blood, before and after treatment with sildenafil (50 mg, thrice a week for 6 weeks).
Data referring to RBC nitrate are reported in Figure 1 . Before treatment with sildenafil, the patients could be divided into two subgroups. One of them had a low penile/systemic nitrate ratio, whereas the other one presented a high ratio. Treatment with the drug, as described above, resulted in a decrease in the ratio in the group of patients whose ratio was high and an increase in this parameter in the patients in whom it was low. In other words, prolonged treatment with sildenafil produced similar ratios (about 1.15) in all the patients.
On the other hand, no similar results were found in the plasma, in which the penile/systemic nitrate ratio did not seem to be affected by sildenafil. Figure 2 shows that plasma nitrate ratios were all similar before treatment and were not sensitive to sildenafil.
Discussion
NO, in the presence of oxygen and water, presents a very short half-life, which makes its direct Erectile dysfunction and NO CA Palmerini et al determination in biological samples impossible. NO rapidly transforms into nitrite by auto-oxidation, 9 and, in the presence of oxyHb, 18, 19 rapidly converts into nitrate. The concentration of nitrate in the blood is usually several orders of magnitude higher that than of nitrite. For this reason, the contribution of nitrite in the variation of nitrate reported in this paper is negligible. 20 The detection electrochemical system used in this study and previously described by us 17 is much more sensitive that the commonly used Griess method. 21 We measure NO, nitrite and nitrate after conversion of nitrite and nitrate to gaseous NO in the detection system.
The origin of nitrate in the human body is not only limited to NO metabolism but may also depend on other metabolic and nutritional processes. 20, 21 For this reason, we compare the levels of plasma and RBC nitrates in the cavernous blood and systemic blood of our patients.
The determination of nitrates in plasma ( Figure 2 ) did not show any variations before or after sildenafil treatment. This finding may be in agreement with previously reported results, 22 in which the authors demonstrated that the amount of NO metabolites does not change after penis erection in cavernous blood with respect to systemic blood.
It has been reported that chronic treatment with sildenafil has a long-term curative effect. 12, 13, 15, 23 Abbreviations: Hb, hemoglobin; PP, penile blood before treatment; PS, penile blood after the treatment with sildenafil; SP, systemic blood before treatment; SS, systemic blood after the treatment with sildenafil. The treatment with sildenafil was performed during 6 weeks (50 mg thrice a week). Systemic blood values were 1.89±0.51 and 1.74±0.27, respectively. Statistics: Student's t-test between the ratios, before and after treatment, was not significant. Patients were divided into two groups: one had a low pre-treatment ratio and the other a high pre-treatment ratio. Analyses of variance were carried out and post-hoc comparison (Scheffé, at P ¼ 0.05) was singled out in three groups of means: low pre-treatment ratio: 0.69, high pretreatment ratio 1.32 and post-treatment ratio: 1.15, in both groups of patients.
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However, no biochemical data have been presented (to our knowledge) to support this finding and/or to propose a mechanism of action for the long-term effects of sildenafil. We investigate RBCs because Hb is a powerful NO scavenger and therefore we expect a better sensitivity in RBC than in plasma nitrate levels. As no diffusion barriers for NO are known to exist between the cells in which NO exerts its effect and in RBCs, we think that the measure of nitrate in these cells might be representative of NO production. However, this consideration might not be final, because little is known about the compartmentation of NO and of its derivatives in penile structures.
Although a difference between the amounts of nitrate in systemic and cavernous RBC is expected, the appearance of two subgroups of patients before sildenafil treatment remains unclear. However, the formation of nitrogen-and oxygen-reactive species and their scavenging effects on NO may explain the decrease in NO. 4, 10 In these patients, sildenafil is expected to increase the biological effects of NO by inhibiting cGMP diesterase and increasing blood flow. Compensatory effects may be responsible for the increase in NO in some patients, which might have a sort of resistance to NO action and, consequently, an increased production of NO. The administration of sildenafil would prolong the life of cGMP, thus covering possible resistance and decreasing NO production.
It is interesting to observe that a prolonged treatment with sildenafil, as carried out in this study, abolishes the difference between the two groups of patients. Moreover, all patients report an improvement in sexual performance. Figure 2 Ratios of penile vs systemic plasma nitrate content before (squares) and after (circles) sildenafil treatment. Penile plasma nitrate (as nmol ml -1 of plasma) was 27.9±7.9 before treatment and 27.2±8.6 after treatment. Systemic blood values were 27.0±6.3 and 26.2±7.1, respectively. Statistics: Comparisons between ratios before and after treatment (1.05 ± 0.05 and 1.04 ± 0.05), performed with Student's t-test, were not significant.
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